MELINDA HALTERMAN: Open Payments
NPI 1184230203 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,629 in 170 payments from 18 companies in 2025. Trend: 2023 $2,280 · 2024 $2,011 · 2025 $2,629
Food & beverage: $2,629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $338 |
| Otsuka America Pharmaceutical, Inc. | 16 | $306 |
| Axsome Therapeutics, Inc. | 19 | $281 |
| Alkermes, Inc. | 15 | $235 |
| Collegium Pharmaceutical, Inc. | 15 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $203 |
| E.R. Squibb & Sons, L.L.C. | 8 | $183 |
| Janssen Pharmaceuticals, Inc | 11 | $180 |
| Supernus Pharmaceuticals, Inc. | 13 | $132 |
| Teva Pharmaceuticals USA, Inc. | 5 | $113 |
Products named: REXULTI, VRAYLAR, Auvelity, ARISTADA, Jornay PM, CAPLYTA, COBENFY, SPRAVATO.
Industry payments across IN — which companies pay providers there.
